Duloxetine versus placebo in the prevention of recurrence of major depressive disorder.

Trial Profile

Duloxetine versus placebo in the prevention of recurrence of major depressive disorder.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Depression; Major depressive disorder
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 10 Dec 2008 Results data presented in a media release from Lilly.
    • 11 May 2008 Status changed from in progress to completed.
    • 14 Aug 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top